Immuneering (IMRX) Shares Outstanding: 2020-2022
Historic Shares Outstanding for Immuneering (IMRX) over the last 3 years, with Dec 2022 value amounting to $26.4 million.
- Immuneering's Shares Outstanding rose 0.37% to $26.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was $26.4 million, marking a year-over-year increase of 0.37%. This contributed to the annual value of $26.4 million for FY2022, which is 0.37% up from last year.
- According to the latest figures from Q4 2022, Immuneering's Shares Outstanding is $26.4 million, which was up 0.05% from $26.4 million recorded in Q3 2022.
- Immuneering's 5-year Shares Outstanding high stood at $26.4 million for Q4 2022, and its period low was $5.0 million during Q2 2020.
- For the 3-year period, Immuneering's Shares Outstanding averaged around $16.6 million, with its median value being $25.9 million (2021).
- Data for Immuneering's Shares Outstanding shows a peak YoY spiked of 432.98% (in 2022) over the last 5 years.
- Quarterly analysis of 3 years shows Immuneering's Shares Outstanding stood at $5.0 million in 2020, then soared by 431.71% to $26.3 million in 2021, then climbed by 0.37% to $26.4 million in 2022.
- Its Shares Outstanding was $26.4 million in Q4 2022, compared to $26.4 million in Q3 2022 and $26.4 million in Q2 2022.